Talc pleurodesis for malignant pleural effusions.
Not Applicable
Completed
- Conditions
- malignant pleural effusion
- Registration Number
- JPRN-UMIN000009175
- Lead Sponsor
- St. Marianna University School of Medicine
- Brief Summary
Talc is considered to be acceptable in both efficacy and safety as sclerosing agent for pleurodesis also in Japanese patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
having insufficient expansion of the lung after pleural fluid drainage (having trapped lung), inadequate lung function parameters, and severe heart failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy. We evaluate at 30, 90, and 180 days after talc pleurodesis by chest radiography.
- Secondary Outcome Measures
Name Time Method Safety. We evaluated any complications requiring additional treatment or procedures within 30 days after talc pleurodesis.